These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26385028)

  • 1. Genetic mutations in African patients with atrial fibrillation: Rationale and design of the Study of Genetics of Atrial Fibrillation in an African Population (SIGNAL).
    Bloomfield GS; Temu TM; Akwanalo CO; Chen PS; Emonyi W; Heckbert SR; Koech MM; Manji I; Shen C; Vatta M; Velazquez EJ; Wessel J; Kimaiyo S; Inui TS
    Am Heart J; 2015 Sep; 170(3):455-64.e5. PubMed ID: 26385028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
    Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
    Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk factors for stroke in Chinese with non valvular atrial fibrillation: a case-control study].
    Hu DY; Sun YH; Zhou ZQ; Li KB; Ni YB; Yang G; Sun SH; Li L
    Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):157-61. PubMed ID: 12816695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Profile of Atrial Fibrillation in a Tertiary Hospital in Central Nepal.
    Dhungel S; Laudari S
    JNMA J Nepal Med Assoc; 2017; 56(207):335-40. PubMed ID: 29255316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya.
    Temu TM; Lane KA; Shen C; Ng'ang'a L; Akwanalo CO; Chen PS; Emonyi W; Heckbert SR; Koech MM; Manji I; Vatta M; Velazquez EJ; Wessel J; Kimaiyo S; Inui TS; Bloomfield GS
    PLoS One; 2017; 12(9):e0185204. PubMed ID: 28934312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-Term Results of Surgical Treatment of Atrial Fibrillation in Valvular Heart Disease Assesed by Speckle Tracking Echocardiography.
    Lorenzo N; Mendez I; Taibo M; Martinis G; Badia S; Reyes G; Aguilar R
    Arq Bras Cardiol; 2018 Apr; 110(4):312-320. PubMed ID: 29561964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated glomerular filtration rate within the normal or mildly impaired range and incident non-valvular atrial fibrillation: Results from a population-based cohort study.
    Eisen A; Haim M; Hoshen M; Balicer RD; Reges O; Leibowitz M; Iakobishvili Z; Hasdai D
    Eur J Prev Cardiol; 2017 Jan; 24(2):213-222. PubMed ID: 27798368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
    Avezum A; Lopes RD; Schulte PJ; Lanas F; Gersh BJ; Hanna M; Pais P; Erol C; Diaz R; Bahit MC; Bartunek J; De Caterina R; Goto S; Ruzyllo W; Zhu J; Granger CB; Alexander JH
    Circulation; 2015 Aug; 132(8):624-32. PubMed ID: 26106009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Marinkovic JM; Lip GY
    Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10-year follow-up.
    Klem I; Wehinger C; Schneider B; Hartl E; Finsterer J; Stöllberger C
    Diabetes Metab Res Rev; 2003; 19(4):320-8. PubMed ID: 12879410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive control and new-onset atrial fibrillation: Results from the Swedish Primary Care Cardiovascular Database (SPCCD).
    Mourtzinis G; Schiöler L; Kahan T; Bengtsson Boström K; Hjerpe P; Hasselström J; Manhem K
    Eur J Prev Cardiol; 2017 Jul; 24(11):1206-1211. PubMed ID: 28470087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients.
    Andersson T; Magnuson A; Bryngelsson IL; Frøbert O; Henriksson KM; Edvardsson N; Poçi D
    Int J Cardiol; 2014 Nov; 177(1):91-9. PubMed ID: 25499348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction.
    Alasady M; Abhayaratna WP; Leong DP; Lim HS; Abed HS; Brooks AG; Mattchoss S; Roberts-Thomson KC; Worthley MI; Chew DP; Sanders P
    Heart Rhythm; 2011 Jul; 8(7):955-60. PubMed ID: 21338715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of anticoagulant treatment in patients with nonvalvular atrial fibrillation: results from atrial fibrillation in Turkey: epidemiologic registry.
    Kaya H; Ertaş F; Köroğlu B; Vatan B; Çağlıyan ÇE; Gedik S; Yeter E; Aydin M; Akil MA; Soydinç MS; Ozhan H; Ülgen MS;
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):144-8. PubMed ID: 23742948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation.
    Padfield GJ; Steinberg C; Swampillai J; Qian H; Connolly SJ; Dorian P; Green MS; Humphries KH; Klein GJ; Sheldon R; Talajic M; Kerr CR
    Heart Rhythm; 2017 Jun; 14(6):801-807. PubMed ID: 28232263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing epidemiology and natural history of nonvalvular atrial fibrillation: clinical implications.
    Gersh BJ; Tsang TS; Seward JB
    Trans Am Clin Climatol Assoc; 2004; 115():149-59; discussion159-60. PubMed ID: 17060964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incident atrial fibrillation hazard in hypertensive population: a risk function from and for clinical practice.
    Alves-Cabratosa L; García-Gil M; Comas-Cufí M; Ponjoan A; Martí R; Parramon D; Blanch J; Ramos R
    Hypertension; 2015 Jun; 65(6):1180-6. PubMed ID: 25847950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Vasiljevic ZM; Vujisic-Tesic BD; Marinkovic JM; Polovina MM; Stepanovic JM; Stankovic GR; Ostojic MC; Lip GYH
    Chest; 2011 Oct; 140(4):902-910. PubMed ID: 21436252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Antiarrhythmic Therapy for Nonvalvular Atrial Fibrillation in Spain. Data From the FANTASIIA Registry.
    Roldán Rabadán I; Anguita Sánchez M; Marín F; Quesada MA; Camacho Siles J; Peinado R; Bertomeu V; Cequier Fillat Á; Badimón L; Muñiz J;
    Rev Esp Cardiol (Engl Ed); 2016 Jan; 69(1):54-60. PubMed ID: 26093482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CHADS2 Score to Predict Stroke Risk in the Absence of Atrial Fibrillation in Hypertensive Patients Aged 65 Years or Older.
    Morillas P; Pallarés V; Fácila L; Llisterri JL; Sebastián ME; Gómez M; Castilla E; Camarasa R; Sandin M; García-Honrubia A;
    Rev Esp Cardiol (Engl Ed); 2015 Jun; 68(6):485-91. PubMed ID: 25487320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.